rolipram has been researched along with Acute Myelogenous Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Copsel, S | 2 |
| Bruzzone, A | 1 |
| May, M | 1 |
| Beyrath, J | 1 |
| Wargon, V | 1 |
| Cany, J | 1 |
| Russel, FG | 2 |
| Shayo, C | 2 |
| Davio, C | 2 |
| Garcia, C | 1 |
| Diez, F | 1 |
| Vermeulem, M | 1 |
| Baldi, A | 1 |
| Bianciotti, LG | 1 |
2 other studies available for rolipram and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Multidrug resistance protein 4/ ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemia.
Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Differentiation; Cell Line, Tumor; Cell Proliferati | 2014 |
Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation.
Topics: Cell Differentiation; Cell Division; Cyclic AMP; Drug Design; HL-60 Cells; Humans; Leukemia, Myeloid | 2011 |